Kathleen Goin, the chief operating officer of Palvella Therapeutics, Inc. (NASDAQ:PVLA), executed the exercise of 4,302 options and immediately sold an equivalent number of common shares on March 18, 2026, according to an SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 4,302 Transaction value ~$508,000 Transaction value based on SEC Form 4 weighted average purchase price ($117.99). Key questions How was this transaction structured, and what does it signal about ...